» Authors » Tatsunori Hanai

Tatsunori Hanai

Explore the profile of Tatsunori Hanai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 957
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Miwa T, Tsuruoka M, Ueda H, Abe T, Inada H, Yukawa-Muto Y, et al.
J Gastroenterol . 2025 Mar; PMID: 40053108
Background: Covert hepatic encephalopathy (CHE) leads to devastating outcomes in patients with cirrhosis. This study aims to elucidate the current management and future perspectives of CHE in Japan. Methods: A...
2.
Unome S, Imai K, Aiba M, Miwa T, Hanai T, Suetsugu A, et al.
Clin Nutr ESPEN . 2025 Feb; 66:454-459. PMID: 39993564
Background & Aim: This study aimed to investigate the prevalence and prognostic impact of cachexia in patients with unresectable hepatocellular carcinoma (HCC) receiving systemic targeted therapy. Methods: This single-center retrospective...
3.
Utakata Y, Miwa T, Hanai T, Aiba M, Unome S, Imai K, et al.
JGH Open . 2025 Feb; 9(2):e70087. PMID: 39927287
Background And Aim: Rapid turnover proteins (RTPs), including retinol-binding protein (RBP), prealbumin, and transferrin, are useful in evaluating dynamic nutritional status. This study aimed to investigate the relationship between serum...
4.
Miwa T, Hanai T, Nishimura K, Hirata S, Unome S, Nakahata Y, et al.
Sci Rep . 2025 Feb; 15(1):4831. PMID: 39924549
This study aimed to evaluate whether the subjective global assessment (SGA) could effectively predict energy malnutrition, as assessed by indirect calorimetry, and mortality in hospitalized patients with cirrhosis. Energy malnutrition...
5.
Imai K, Takai K, Aiba M, Unome S, Miwa T, Hanai T, et al.
Cancers (Basel) . 2025 Jan; 17(2. PMID: 39857991
Background: This study aimed to investigate the usefulness of the psoas muscle index (PMI) as an independent predictor of survival after systemic targeted therapy initiation in patients with hepatocellular carcinoma...
6.
Hanai T, Nishimura K, Unome S, Miwa T, Nakahata Y, Imai K, et al.
J Gastroenterol . 2024 Oct; 59(12):1144-1145. PMID: 39365312
No abstract available.
7.
Imai K, Takai K, Aiba M, Unome S, Miwa T, Hanai T, et al.
Cancers (Basel) . 2024 Sep; 16(18). PMID: 39335121
To assess the impact of adverse event (AE) severity, caused by targeted therapy, on overall survival (OS) and progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC), a total...
8.
Hanai T, Nishimura K, Unome S, Miwa T, Nakahata Y, Imai K, et al.
J Gastroenterol . 2024 Jul; 59(10):932-940. PMID: 39068612
Background: Rapid skeletal muscle loss adversely affects the clinical outcomes of liver cirrhosis. However, the relationships between the annual changes in skeletal muscle area (ΔSMA/year) and the etiology of cirrhosis,...
9.
Miwa T, Hanai T, Hirata S, Nishimura K, Sahashi Y, Unome S, et al.
Clin Nutr ESPEN . 2024 Jul; 63:267-273. PMID: 38972037
Backgrounds & Aims: This study aimed to investigate the association between vitamin D deficiency and covert hepatic encephalopathy (CHE), overt hepatic encephalopathy (OHE) occurrence, and mortality in patients with cirrhosis....
10.
Miwa T, Tajirika S, Imamura N, Adachi M, Horita R, Hanai T, et al.
JGH Open . 2024 Jun; 8(6):e13110. PMID: 38895100
Aims: The application of indices in the context of metabolic dysfunction-associated steatotic liver disease (MASLD) remains unexplored. We aimed to validate the ability of alanine aminotransferase (ALT), fatty liver index...